In the pharmaceutical industry, contract updates, chargeback claims and credits are shared between trading partners through EDI 845, EDI 844 and EDI 849. Due to reliance on these EDI messages, roughly 4% of chargebacks result in errors causing revenue leakage, cash flow delays, and manual effort for everyone.
‍
This guide explains why the time has come to move beyond EDI to blockchain-based solutions in pharma contracting and chargebacks.

EDI to blockchain-based solutions:

EDI 845 to Real-time & Aligned Contract Updates

EDI 844 to Blockchain Enforced Chargeback Accuracy

EDI 849 to Automatically Generated Credit Memos